LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 11 of 497
Next
>>
>
251 to 275 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PHA-665752	0.04	uM	LJP5	3	F18	72	hr	1097	4041	3769	1.0720	1.1016
BT-20	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1097	3581	3769	0.9500	0.9295
BT-20	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1097	3729	3769	0.9893	0.9848
BT-20	Mitoxantrone	0.12	uM	LJP5	1	C23	72	hr	1097	1026	3769	0.2722	-0.0267
BT-20	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1097	4053	3769	1.0752	1.1061
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1097	3349	3769	0.8884	0.8426
BT-20	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1097	4031	3769	1.0694	1.0978
BT-20	PLX-4720	0.04	uM	LJP5	1	K06	72	hr	1097	3531	3769	0.9367	0.9107
BT-20	PLX-4720	0.04	uM	LJP5	2	K06	72	hr	1097	3791	3769	1.0057	1.0080
BT-20	PLX-4720	0.04	uM	LJP5	3	K06	72	hr	1097	3998	3769	1.0606	1.0855
BT-20	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1097	3202	3769	0.8494	0.7876
BT-20	Ruxolitinib	0.04	uM	LJP5	3	O18	72	hr	1097	3975	3769	1.0545	1.0769
BT-20	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1097	3808	3769	1.0102	1.0144
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1097	2788	3769	0.7396	0.6327
BT-20	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1097	3945	3769	1.0465	1.0657
BT-20	SU11274	0.04	uM	LJP5	2	J12	72	hr	1097	3959	3769	1.0503	1.0709
BT-20	Radicicol	0.04	uM	LJP5	1	K12	72	hr	1097	3156	3769	0.8372	0.7704
BT-20	Radicicol	0.04	uM	LJP5	2	K12	72	hr	1097	3286	3769	0.8717	0.8191
BT-20	Radicicol	0.04	uM	LJP5	3	K12	72	hr	1097	3147	3769	0.8349	0.7670
BT-20	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1097	4326	3769	1.1476	1.2082
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1097	3757	3769	0.9967	0.9953
BT-20	TGX221	0.04	uM	LJP5	3	H24	72	hr	1097	3742	3769	0.9927	0.9897
BT-20	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1097	3907	3769	1.0365	1.0514
BT-20	Nilotinib	0.12	uM	LJP5	2	N17	72	hr	1097	4377	3769	1.1612	1.2273
BT-20	Nilotinib	0.12	uM	LJP5	1	N17	72	hr	1097	3967	3769	1.0524	1.0739

|<
<<
Previous
Page 11 of 497
Next
>>
>
251 to 275 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)